Jorge R Bernett, MD
Infectious Disease · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 2
- Since medical school
- 37 years
- University of California, San Francisco School of Medicine, 1989
Offices
2 locations · Bass Medical Group · 292 clinicians in this group
Hospitals listed: John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus · Sutter Delta Medical Center · Sutter Solano Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bernett’s office at (925) 932-6330 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
California Medical Board record
Licence G70835 · Current
Licensed to practise in California · since 1991 · expires 2027-02-28 · University of California San Francisco School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Infectious Disease
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
- Sutter Delta Medical CenterAntioch, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 2 of 5 · 60% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.173, Oct 2024 – Sep 2025
- Sutter Solano Medical CenterVallejo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.272, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Delta Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.173 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.98 (0 to 2.03) · 561 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.47 to 1.29) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 176.46 (114.75 to 238.17) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.3 · 260 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.2 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 56 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 1,274 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.02 to 0.46) · 3,285 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,374 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.47 (1.02 to 5.93) · 364 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.16 (0.49 to 3.83) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.63 (0 to 18.4) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 81 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.24 (0 to 1.07) · 2,713 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.962 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.1 · 116 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 316 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 20 · 83 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.1 · 298 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 27.3 · 269 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 283 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (9.7 to 17.1) · 529 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 45 cases | No different | Jan 2024 – Dec 2024 |
What patients said (610 patients answered, 13% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 2 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 72% |
| Staff "always" explained | 53% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 60% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 64% |
| Nurses "always" listened carefully | 66% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Sutter Solano Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 8 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.272 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.93 (0 to 1.95) · 374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.6 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 162.36 (106.6 to 218.11) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.3 · 77 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.9 · 28 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.2 · 113 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.2 · 154 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 65 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 960 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,268 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 2,327 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.7 (0.38 to 5.03) · 594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.61 (0 to 3.31) · 285 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.78) · 581 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.1 (0 to 16.32) · 302 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.77 (3.74 to 11.8) · 275 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 114 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.59 (0 to 1.48) · 1,998 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.8 · 171 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.8 · 131 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 33 · 162 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 160 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.5) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (6.8 to 14.4) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14.2 (10.6 to 18.9) · 322 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.6) · 84 cases | No different | Jan 2024 – Dec 2024 |
What patients said (355 patients answered, 17% of those asked)
| Cleanliness | 2 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 63% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$139,064
Medicare paid this office $139,064 for 381 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 295 | $89,103 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 126 | $21,995 | $165 |
| Long return visit (40+ min) | 28 | $7,151 | $179 |
| Critical care, first 30-74 minutes | 30 | $6,751 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,566 | $75 |
See all 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 295 | $89,103 | $113 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 126 | $21,995 | $165 |
| Long return visit (40+ min) | 28 | $7,151 | $179 |
| Critical care, first 30-74 minutes | 30 | $6,751 | $199 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,566 | $75 |
| Return visit (30+ min) | 11 | $1,689 | $106 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $564 | $47 |
Who their Medicare patients are
381 Original Medicare patients in 2024. Average age 73 · Under 65 16% · 85 and older 18% · Women 44% · Also on Medicaid 46% · Health risk score 3.56. Above the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 75% · Chronic kidney disease 56% · Diabetes 51% · Heart failure 48% · Atrial fibrillation 41% · Depression 41% · Coronary heart disease 40% · COPD 38% · Dementia 28% · Stroke 24% · Cancer 18%.
The office billed $488,802, Medicare allowed $172,451 and paid $139,064; for 1,648 services of 19 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 381 | 1,648 | 73 | 3.56 | $488,802 | $139,064 |
| 2023 | 400 | 3,652 | 73 | 3.40 | $555,875 | $147,696 |
| 2022 | 523 | 1,414 | 73 | 3.14 | $567,021 | $150,064 |
| 2021 | 506 | 5,167 | 74 | 3.09 | $649,466 | $170,640 |
| 2020 | 488 | 58,141 | 72 | 3.67 | $821,780 | $180,078 |
| 2019 | 505 | 2,302 | 71 | 3.77 | $607,702 | $166,794 |
| 2018 | 473 | 6,169 | 71 | 3.65 | $637,239 | $164,204 |
| 2017 | 455 | 3,490 | 72 | 3.59 | $552,150 | $139,156 |
| 2016 | 475 | 3,676 | 72 | 3.50 | $530,609 | $136,521 |
| 2015 | 582 | 12,915 | 73 | 3.34 | $377,628 | $155,215 |
| 2014 | 572 | 2,212 | 72 | 3.00 | $276,809 | $132,542 |
| 2013 | 564 | 13,434 | 73 | 3.13 | $297,472 | $127,751 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 309 | $76,729 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 115 | $19,087 | $156 |
| Critical care, first 30-74 minutes | 42 | $9,247 | $189 |
| Long return visit (40+ min) | 24 | $6,220 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $3,511 | $72 |
| Return visit (30+ min) | 19 | $2,582 | $99 |
| New patient visit (60+ min) | 11 | $1,642 | $149 |
2022: 10 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 340 | $76,270 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 156 | $29,451 | $177 |
| Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 26 | $11,816 | $454 |
| Critical care, first 30-74 minutes | 38 | $8,089 | $188 |
| Long return visit (40+ min) | 25 | $4,681 | $142 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $4,283 | $64 |
| Return visit (30+ min) | 34 | $4,238 | $94 |
| New patient visit (30+ min) | 37 | $3,582 | $97 |
| Short return visit (20+ min) | 11 | $1,306 | $82 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 17 | $762 | $35 |
2021: 11 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 322 | $75,190 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 154 | $29,308 | $181 |
| Critical care, first 30-74 minutes | 59 | $12,953 | $196 |
| Return visit (30+ min) | 41 | $8,099 | $121 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 85 | $7,311 | $65 |
| Long return visit (40+ min) | 29 | $6,652 | $155 |
| New patient visit (60+ min) | 14 | $2,772 | $198 |
| Short return visit (20+ min) | 18 | $2,116 | $85 |
| New patient visit (45+ min) | 11 | $1,644 | $149 |
| New patient visit (30+ min) | 12 | $970 | $81 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $660 | $35 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 348 | $79,227 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 166 | $31,781 | $184 |
| Critical care, first 30-74 minutes | 40 | $9,568 | $195 |
| Long return visit (40+ min) | 49 | $8,515 | $120 |
| Return visit (30+ min) | 35 | $5,363 | $105 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $3,335 | $67 |
| Short return visit (20+ min) | 11 | $1,095 | $73 |
2019: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 372 | $85,157 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 180 | $35,061 | $181 |
| Critical care, first 30-74 minutes | 65 | $17,004 | $195 |
| Long return visit (40+ min) | 61 | $12,484 | $129 |
| New patient visit (60+ min) | 18 | $3,459 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $1,832 | $65 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $424 | $35 |
2018: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 340 | $77,734 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 160 | $30,229 | $178 |
| Critical care, first 30-74 minutes | 56 | $15,144 | $194 |
| Long return visit (40+ min) | 57 | $12,593 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $3,687 | $65 |
| New patient visit (60+ min) | 16 | $2,675 | $167 |
2017: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 284 | $51,850 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 153 | $27,740 | $173 |
| Critical care, first 30-74 minutes | 45 | $12,917 | $190 |
| Long return visit (40+ min) | 59 | $11,156 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 99 | $8,464 | $63 |
| New patient visit (60+ min) | 15 | $2,776 | $185 |
| Return visit (30+ min) | 13 | $1,246 | $83 |
2016: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 257 | $44,706 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 136 | $24,115 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 167 | $14,136 | $61 |
| Critical care, first 30-74 minutes | 51 | $14,126 | $188 |
| Long return visit (40+ min) | 48 | $9,286 | $122 |
| New patient visit (60+ min) | 19 | $3,450 | $182 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,758 | $117 |
| Return visit (30+ min) | 14 | $1,426 | $95 |
2015: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 287 | $47,378 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 160 | $29,493 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 273 | $26,277 | $62 |
| Critical care, first 30-74 minutes | 59 | $14,421 | $190 |
| Long return visit (40+ min) | 47 | $7,573 | $126 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 35 | $4,121 | $118 |
| Return visit (30+ min) | 26 | $2,416 | $86 |
| New patient visit (60+ min) | 12 | $2,187 | $182 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $604 | $34 |
2014: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 226 | $32,977 | $89 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 304 | $31,636 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 155 | $27,288 | $174 |
| Critical care, first 30-74 minutes | 50 | $11,359 | $189 |
| Long return visit (40+ min) | 40 | $6,035 | $110 |
| Return visit (30+ min) | 39 | $5,304 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $4,590 | $115 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $604 | $34 |
2013: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 380 | $40,684 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 130 | $22,165 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 130 | $17,947 | $87 |
| Return visit (30+ min) | 62 | $8,621 | $89 |
| Critical care, first 30-74 minutes | 33 | $7,553 | $184 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 57 | $6,801 | $115 |
| Long return visit (40+ min) | 17 | $2,109 | $105 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 15 | $489 | $33 |
Medicaid work
$15,415 in 2024
Medicaid paid $15,415 for 322 billed services this clinician did in 2024, up to 26 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 298 | $13,333 |
| 1ST HOSP IP/OBS HIGH 75 | 24 | $2,082 |
| 2024 | 322 | 2 | 26 | $15,415 |
| 2023 | 419 | 1 | 25 | $22,290 |
| 2022 | 331 | 2 | 22 | $22,356 |
| 2021 | 205 | 2 | 21 | $16,425 |
| 2020 | 305 | 2 | 31 | $21,297 |
| 2019 | 213 | 2 | 23 | $14,936 |
| 2018 | 242 | 2 | 30 | $11,464 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 419 | $22,290 |
2022
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 297 | $18,009 |
| 1ST HOSP IP/OBS HIGH 75 | 34 | $4,347 |
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 179 | $11,753 |
| 1ST HOSP IP/OBS HIGH 75 | 26 | $4,673 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 290 | $19,349 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $1,948 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 198 | $12,821 |
| 1ST HOSP IP/OBS HIGH 75 | 15 | $2,115 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 209 | $8,682 |
| 1ST HOSP IP/OBS HIGH 75 | 33 | $2,782 |
Drugs they prescribed that Part D paid
$669,315
Pharmacies billed $669,315 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 347) in 2024. At or below the middle of the specialty; the typical infectious disease clinician is at 0%.
213 generic and fewer than 11 brand-name prescriptions · $669,315 in drug cost · 101 antibiotic prescriptions to 28 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Genvoya | 19 | $134,139 | $7,060 |
| Biktarvy | 27 | $103,075 | $3,818 |
| Triumeq | 20 | $95,953 | $4,798 |
| Tivicay | 23 | $70,464 | $3,064 |
| Descovy | 16 | $55,776 | $3,486 |
See all 11 drugs
| Genvoya | 19 | $134,139 | $7,060 |
| Biktarvy | 27 | $103,075 | $3,818 |
| Triumeq | 20 | $95,953 | $4,798 |
| Tivicay | 23 | $70,464 | $3,064 |
| Descovy | 16 | $55,776 | $3,486 |
| Maraviroc | 24 | $23,731 | $989 |
| Darunavir | 25 | $17,642 | $706 |
| Ritonavir | 16 | $2,320 | $145 |
| Entecavir | 16 | $1,320 | $82 |
| Dicloxacillin | 11 | $765 | $70 |
| Sulfamethoxazole-Trimethoprim | 19 | $217 | $11 |
Year by year
| 2024 | 347 | 48 | 0% (0) | None | $669,315 |
| 2023 | 357 | 48 | 0% (0) | None | $862,657 |
| 2022 | 388 | 53 | None | None | $747,750 |
| 2021 | 309 | 41 | 4% (12) | 60% | $683,273 |
| 2020 | 340 | 49 | 4% (12) | 48% | $603,573 |
| 2019 | 377 | 48 | None | 51% | $517,792 |
| 2018 | 358 | 56 | None | 43% | $560,257 |
| 2017 | 355 | 60 | 4% (15) | 39% | $388,271 |
| 2016 | 412 | 63 | 4% (18) | 42% | $416,854 |
| 2015 | 352 | 58 | None | 47% | $460,412 |
| 2014 | 258 | 48 | 5% (13) | 34% | $337,000 |
| 2013 | 257 | 42 | None | 48% | $242,188 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Genvoya | 20 | $130,825 | $6,541 |
| Biktarvy | 24 | $97,841 | $4,077 |
| Triumeq | 15 | $94,543 | $6,303 |
| Juluca | 12 | $51,347 | $4,279 |
| Tivicay | 16 | $44,588 | $2,787 |
| Prezista | 17 | $43,076 | $2,534 |
| Descovy | 12 | $40,879 | $3,407 |
| Maraviroc | 17 | $20,999 | $1,235 |
| Voriconazole | 14 | $6,392 | $457 |
| Ritonavir | 14 | $6,282 | $449 |
| Dicloxacillin | 13 | $911 | $70 |
| Entecavir | 17 | $574 | $34 |
| Cefuroxime | 11 | $327 | $30 |
| Amoxicillin | 13 | $316 | $24 |
| Sulfamethoxazole-Trimethoprim | 21 | $247 | $12 |
2022: 14 drugs
| Genvoya | 30 | $173,239 | $5,775 |
| Triumeq | 26 | $120,530 | $4,636 |
| Odefsey | 22 | $77,879 | $3,540 |
| Prezista | 17 | $52,051 | $3,062 |
| Biktarvy | 12 | $46,389 | $3,866 |
| Descovy | 13 | $45,839 | $3,526 |
| Juluca | 13 | $40,878 | $3,144 |
| Ritonavir | 15 | $5,531 | $369 |
| Azithromycin | 15 | $526 | $35 |
| Sulfamethoxazole-Trimethoprim | 23 | $287 | $12 |
| Amoxicillin | 11 | $206 | $19 |
| Mirtazapine | 11 | $205 | $19 |
| Rosuvastatin | 11 | $193 | $18 |
| Fluoxetine | 11 | $187 | $17 |
2021: 10 drugs
| Genvoya | 31 | $161,736 | $5,217 |
| Odefsey | 25 | $84,164 | $3,367 |
| Triumeq | 16 | $81,152 | $5,072 |
| Prezista | 22 | $47,695 | $2,168 |
| Descovy | 13 | $43,708 | $3,362 |
| Juluca | 14 | $40,519 | $2,894 |
| Selzentry | 18 | $23,383 | $1,299 |
| Ritonavir | 12 | $5,554 | $463 |
| Sulfamethoxazole-Trimethoprim | 21 | $148 | $7 |
| Tramadol | 12 | $29 | $2 |
2020: 9 drugs
| Genvoya | 23 | $109,588 | $4,765 |
| Odefsey | 23 | $71,173 | $3,094 |
| Triumeq | 13 | $65,702 | $5,054 |
| Prezista | 26 | $62,052 | $2,387 |
| Descovy | 18 | $53,039 | $2,947 |
| Selzentry | 18 | $30,858 | $1,714 |
| Sulfamethoxazole-Trimethoprim | 26 | $207 | $8 |
| Amoxicillin | 11 | $179 | $16 |
| Tramadol | 12 | $50 | $4 |
2019: 12 drugs
| Genvoya | 25 | $98,555 | $3,942 |
| Odefsey | 25 | $73,267 | $2,931 |
| Triumeq | 13 | $62,879 | $4,837 |
| Descovy | 34 | $60,457 | $1,778 |
| Prezista | 27 | $48,582 | $1,799 |
| Noxafil | 11 | $48,158 | $4,378 |
| Selzentry | 17 | $25,798 | $1,518 |
| Tivicay | 13 | $23,027 | $1,771 |
| Ritonavir | 15 | $4,412 | $294 |
| Cephalexin | 26 | $2,617 | $101 |
| Amoxicillin | 16 | $268 | $17 |
| Sulfamethoxazole-Trimethoprim | 18 | $138 | $8 |
2018: 12 drugs
| Genvoya | 20 | $63,038 | $3,152 |
| Odefsey | 21 | $53,996 | $2,571 |
| Noxafil | 12 | $49,132 | $4,094 |
| Descovy | 27 | $44,879 | $1,662 |
| Tivicay | 13 | $21,721 | $1,671 |
| Prezista | 13 | $20,204 | $1,554 |
| Cefepime | 11 | $1,709 | $155 |
| Doxycycline Monohydrate | 14 | $1,230 | $88 |
| Clindamycin | 13 | $379 | $29 |
| Amoxicillin | 11 | $232 | $21 |
| Atorvastatin | 13 | $173 | $13 |
| Nevirapine | 13 | $159 | $12 |
2017: 11 drugs
| Triumeq | 17 | $58,680 | $3,452 |
| Noxafil | 12 | $47,332 | $3,944 |
| Atripla | 18 | $45,570 | $2,532 |
| Descovy | 19 | $29,578 | $1,557 |
| Tivicay | 13 | $19,593 | $1,507 |
| Prezista | 11 | $16,081 | $1,462 |
| Fluconazole | 12 | $1,102 | $92 |
| Amoxicillin-Clavulanate Potass | 11 | $521 | $47 |
| Amoxicillin | 28 | $359 | $13 |
| Sulfamethoxazole-Trimethoprim | 14 | $284 | $20 |
| Cephalexin | 14 | $197 | $14 |
2016: 14 drugs
| Atripla | 29 | $69,140 | $2,384 |
| Noxafil | 11 | $41,551 | $3,777 |
| Tivicay | 27 | $38,329 | $1,420 |
| Rifabutin | 17 | $11,033 | $649 |
| Abacavir | 12 | $2,675 | $223 |
| Lamivudine | 12 | $1,087 | $91 |
| Ethambutol | 14 | $867 | $62 |
| Cephalexin | 29 | $691 | $24 |
| Amoxicillin-Clavulanate Potass | 16 | $589 | $37 |
| Levofloxacin | 16 | $469 | $29 |
| Amoxicillin | 13 | $206 | $16 |
| Sulfamethoxazole-Trimethoprim | 15 | $180 | $12 |
| Isoniazid | 17 | $164 | $10 |
| Tramadol | 12 | $42 | $4 |
2015: 11 drugs
| Atripla | 28 | $77,053 | $2,752 |
| Stribild | 20 | $51,970 | $2,598 |
| Noxafil | 12 | $43,998 | $3,667 |
| Truvada | 13 | $28,606 | $2,200 |
| Tivicay | 19 | $25,471 | $1,341 |
| Epzicom | 12 | $14,127 | $1,177 |
| Vancomycin | 13 | $13,220 | $1,017 |
| Doxycycline Hyclate | 13 | $1,162 | $89 |
| Cephalexin | 32 | $1,009 | $32 |
| Amoxicillin-Clavulanate Potass | 13 | $524 | $40 |
| Rifampin | 13 | $424 | $33 |
2014: 10 drugs
| Noxafil | 17 | $58,119 | $3,419 |
| Stribild | 20 | $50,609 | $2,530 |
| Atripla | 16 | $47,193 | $2,950 |
| Fluconazole | 12 | $3,277 | $273 |
| Cephalexin | 42 | $901 | $21 |
| Valacyclovir | 11 | $793 | $72 |
| Rifampin | 20 | $754 | $38 |
| Amox Tr-Potassium Clavulanate | 14 | $739 | $53 |
| Hydrocodone-Acetaminophen | 13 | $196 | $15 |
| Azithromycin | 15 | $192 | $13 |
2013: 10 drugs
| Atripla | 25 | $59,441 | $2,378 |
| Noxafil | 17 | $54,279 | $3,193 |
| Truvada | 17 | $28,515 | $1,677 |
| Isentress | 14 | $15,451 | $1,104 |
| Viramune Xr | 11 | $6,689 | $608 |
| Fluconazole | 13 | $2,789 | $215 |
| Doxycycline Hyclate | 12 | $948 | $79 |
| Cephalexin | 31 | $860 | $28 |
| Amox Tr-Potassium Clavulanate | 12 | $693 | $58 |
| Amoxicillin | 12 | $203 | $17 |
Money from drug and device companies
$299 in 2025
| 2025 | 4 | 4 | None | $299 |
| 2024 | 2 | 2 | None | $204 |
| 2023 | 5 | 7 | None | $392 |
| 2022 | 2 | 6 | None | $176 |
| 2020 | 1 | 2 | None | $138 |
| 2019 | 3 | 6 | None | $501 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aimmune Therapeutics | Zenpep | $125 | 1 payment
|
| Paratek Pharmaceuticals | Nuzyra | $122 | 1 payment
|
| Gilead Sciences | None | $26 | 1 payment
|
| Merck Sharp & Dohme | Zerbaxa | $26 | 1 payment
|
See all 4 published payments
| Merck Sharp & Dohme | Education · 2025-04-30 | Zerbaxa | $26 |
| Gilead Sciences | Meals · 2025-04-23 | None | $26 |
| Paratek Pharmaceuticals | Meals · 2025-03-18 | Nuzyra | $122 |
| Aimmune Therapeutics | Meals · 2025-02-05 | Zenpep | $125 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $204
| La Jolla Pharmaceutical | Xerava | $122 | 1 payment
|
| Medtronic | Venaseal | $82 | 1 payment
|
2023: $392
| Merck Sharp & Dohme | Recarbrio | $136 | 3 payments
|
| GlaxoSmithKline | Shingrix | $122 | 1 payment
|
| La Jolla Pharmaceutical | Xerava | $96 | 1 payment
|
| ViiV Healthcare | Cabenuva | $24 | 1 payment
|
| Shionogi | Fetroja | $13 | 1 payment
|
2022: $176
| Merck Sharp & Dohme | Zerbaxa | $159 | 5 payments
|
| Insmed | Arikayce | $16 | 1 payment
|
2020: $138
| Allergan | Dalvance | $138 | 2 payments
|
2019: $501
| Gilead Sciences | Epclusa | $272 | 3 payments
|
| Merck Sharp & Dohme | Zerbaxa | $115 | 2 payments
|
| Oxford Immunotec USA | Tspot Tb Test | $114 | 1 payment
|
Checkups this office reported
10 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 88.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 63%That's more than half. | 49 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 87%That's most of the people this applied to. | 31 |
| Checked for fall riskOlder patients screened for fall risk | 44%That's less than half. | 39 |
| Colon cancer screeningEligible adults who got a colon cancer test | 43%That's less than half. | 63 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 27%That's less than half. | 66 |
| HIV screeningEligible patients who were screened for HIV | 35%That's less than half. | 49 |
| Medications listed in the chartVisits where the current medication list was documented | 62%That's more than half. | 198 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 100%That's most of the people this applied to. | 61 |
See the other 2 measures
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 82%That's most of the people this applied to. | 38 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 30%That's less than half. | 98 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Did a security review of patient data
- Exchanges records both ways with other health systems
- Improved the patient portal
- Lets patients read their visit notes
- Reports cases to public health electronically
- Reports immunizations to the state registry
- Shows lab and imaging costs when ordering tests
- Uses standard treatment protocols
- Exempt from query of the prescription drug monitoring program (pdmp)
Professional record
- NPI
- 1366460081
- Licence
- CA G70835California G70835: Current · expires 2027-02-28
- Trained
- University of California, San Francisco School of Medicine, 1989 · 37 years ago
- Group
- Bass Medical Group
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G708350
- Taxonomy
- Federal specialty code 207RI0200X (207RI0200X)
- Mailing address
- 365 Lennon Ln, Suite 200, Walnut Creek, CA, 94598
- NPI first listed
- 2006-07-18
- NPI last updated
- 2008-01-30
This is when the NPI record was last certified, not a medical board exam.